- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03798990
Reduce Speed Limits From 90km/h to 80 km/h on French Roads: Impact on Mortality
Reduce Speed Limits From 90km/h to 80 km/h on French Two-way Roads Without Central Separator: the Number of Traffic Related Fatalities on the Network Concerned "Before and After" the Reduction of Speed Limits.
On the first July 2018, the French government lowered the maximum authorized speeds on two-way roads without a central separator from 90 km/h to 80 km/h. The network concerned represents approximately 400 000 km of roads outside the built-up area, accounting for 55% of road deaths.
The objective of the measure is to reduce the number of deaths on the roads concerned by encouraging the reduction of the average speed practiced by drivers.
The analysis deals with a comparison of the number of killed persons on the network concerned, before and after the reduction of the speed limits. The "before" period is 2015-2017. The "after" period is from July 2018 to June 2019.
The data used are extracted from the national bodily injury accident file (BAAC). The police fills this file for each road accidents occurring on a road open to public traffic and causing at least one victim (i.e., one user requiring medical care and involving at least one vehicle).
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Lyon, France
- Recruiting
- Cerema
-
Contact:
- David Chupin
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- people who circulate on French non-motorway non-urban roads during the period of the study
- any person who dies in a road accident on this network during the period of the study, who either dies instantly or within 30 days of the accident, due to the consequences of the accident
Exclusion Criteria:
- all persons involved in an accident on a private road
- all persons involved in a road accident without a motor vehicle
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
users of French roads
all road users circulating on French roads outside over-seas
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evolution of the number of fatalities in road accidents before and after the implementation of the measure
Time Frame: before period: 2015-2017 / after period: July 2018- June 2019
|
the number of fatalities in road accidents on non-motorway non-urban roads during the period July 2018-June 2019 ("after" the measure) compared to the number of fatalities during the period 2015-2017 ("before" the measure)
|
before period: 2015-2017 / after period: July 2018- June 2019
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sub-groups analysis of road fatalities, by type of road users, before and after the implementation of the measure
Time Frame: before period: 2015-2017 / after period: July 2018- June 2019
|
For each type of road users, the number of fatalities in road accidents on non-motorway non-urban roads during the period July 2018-June 2019 ("after" the measure) compared to the number of fatalities during the period 2015-2017 ("before" the measure)
|
before period: 2015-2017 / after period: July 2018- June 2019
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Marine Millot, PhD, Centre d'études et d'expertise sur les risques, l'environnement, la mobilité et l'aménagement
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2018-12
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Death
-
Amasya UniversityHealth Institutes of TurkeyCompleted
-
Johns Hopkins Bloomberg School of Public HealthEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedSudden Infant Death SyndromeUnited States
-
Weill Medical College of Cornell UniversityEmpatica, Inc.Terminated
-
Children's Hospital Medical Center, CincinnatiEvery Child Succeeds; de Cavel Family SIDS FoundationCompletedSudden Infant Death Syndrome (SIDS)United States
-
Rachel Moon, MDCompletedSudden Infant Death SyndromeUnited States
-
National Center for Research Resources (NCRR)CompletedSudden Infant Death Syndrome
-
Harvard School of Public Health (HSPH)Population Services International; Community Empowerment LabCompletedPerinatal Death | Stillbirth | Neonatal DeathIndia
-
Johns Hopkins UniversityAmerican SIDS InstituteActive, not recruiting
-
Ondokuz Mayıs UniversityCompleted
-
University of ZurichCompleted